Role of the complement system in cancer progression and therapy

Speaker: Marcin Okrój, PhD

Talk: Role of the complement system in cancer progression and therapy.

Time: 26 February 2016, 9.00

Venue: Intercollegiate Faculty of Biotechnology, Abrahama 58

Category: Faculty seminar


Marcin OkrójMarcin Okrój obtained his master degree at the Intercollegiate Faculty of Biotechnology UG-AMG (Gdańsk, Poland) in 1999, then continued his scientific career at the same place as a PhD student under the supervision of prof. Jacek Bigda. He participated in two projects granted by Polish State Commitee for Scientific Research (KBN), which involved the role of cell adhesion as well as antiangiogenic compound TNP-470 in growth of rodent melanomas. Irrespectively of the main scientific activity, he was also involved in several side-projects concerning antimicrobial peptides. In 2003, as a beneficient of Marie-Curie Program, he obtained 6-month training at the Free University of Amsterdam (Amsterdam, The Netherlands) and finally defended his PhD thesis in 2004.

After working for 1 year at Pasteur Institute (Paris, France), Dr Okrój joined the team of prof. Anna Blom at Lund University (Malmö, Sweden), which was engaged into innate immunity and especially the complement system. In 2010 he obtained support from Swedish Research Council (Vetenskapsrådet) and initiated an independent line of research focused on the role of complement in tumor progression, identification of novel complement inhibitors and design of new immunological methods.

Currently Dr Okrój is a principal investigator within two projects funded by National Science Centre (NCN, Poland): i) ¨Role of the complement system in tumorigenesis and therapeutic approaches.¨ (Sonata Bis) and ii) ¨Functional characteristics and therapeutic potential of gain-of-function mutations in complement C2 protein.¨ (Harmonia). He is the author of 30 peer-reviewed publications and named as inventor in one patent. Dr Okrój is a member of International Complement Society, European Complement Network and research program Biomarkers in Cancer Medicine (BioCare).

Załącznik Rozmiar
Abstract 93.31 KB
Pokaż rejestr zmian

Data publikacji: czwartek, 4. luty 2016 - 08:30; osoba wprowadzająca: Katarzyna Maczyszyn Ostatnia zmiana: wtorek, 28. Listopad 2017 - 11:47; osoba wprowadzająca: Katarzyna Maczyszyn